Update of the statements on biology and clinical impact of occult hepatitis B virus infection
Autor:
Raimondo, Giovanni
; Locarnini, Stephen
; Pollicino, Teresa
; Levrero, Massimo
; Zoulim, Fabien
; Lok, Anna S.
; Soriano, Vicente
; ...et al.
; Taormina Workshop on Occult HBV Infection Faculty Members
Fecha:
08/2019Palabra clave:
Revista / editorial:
Journal of HepatologyTipo de Ítem:
Articulo Revista IndexadaResumen:
In October 2018 a large number of international experts with complementary expertise came together in Taormina to participate in a workshop on occult hepatitis B virus infection (OBI). The objectives of the workshop were to review the existing knowledge on OBI, to identify issues that require further investigation, to highlight both existing controversies and newly emerging perspectives, and ultimately to update the statements previously agreed in 2008. This paper represents the output from the workshop.
Este ítem aparece en la(s) siguiente(s) colección(es)
Estadísticas de uso
Año |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Vistas |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
69 |
69 |
32 |
37 |
38 |
75 |
Descargas |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
The Importance of Understanding the Stages of COVID-19 in Treatment and Trials
Griffin, Daniel O.; Brennan-Rieder, Denise; Ngo, Binh; Kory, Pierre; Confalonieri, Marco; Shapiro, Leland; Iglesias, Jose; Dube, Michael; Nanda, Neha; In, Gino K.; Arkfeld, Daniel; Chaudhary, Preet; Campese, Vito M.; Hanna, Diana L.; Sawcer, David; Ehresmann, Glenn; Peng, David; Smorgorzewski, Miroslaw; Amstrong, April; Vinjevoll, Eivind H.; Dasgupta, Rajkumar; Sattler, Fred R.; Mussini, Cristina; Mitjà, Oriol; Soriano, Vicente ; Peschanski, Nicolas; Hayem, Gilles; Piccirillo, Maria Carmela; Lobo-Ferreira, António; B. Rivero, Iraldo; Hung, Ivan F. H.; Rendell, Marc; Ditmore, Stephen; Varon, Joseph; Marik, Paul (AIDS reviews, 2021)COVID-19, caused by SARS-CoV-2, continues to be a major health problem since its first description in Wuhan, China, in December 2019. Multiple drugs have been tried to date in the treatment of COVID-19. Critical to treatment ... -
The time to offer treatments for COVID-19
Ngo, Binh T.; Marik, Paul; Kory, Pierre; Shapiro, Leland; Thomadsen, Raphael; Iglesias, Jose; Ditmore, Stephen; Rendell, Marc; Varon, Joseph; Dube, Michael; Nanda, Neha; In, Gino K.; Arkfeld, Daniel; Chaudhary, Preet; Campese, Vito M.; Hanna, Diana L.; Sawcer, David E.; Ehresmann, Glenn; Peng, David; Smorgorzewski, Miroslaw; Armstrong, April; Dasgupta, Rajkumar; Sattler, Fred R.; Brennan-Rieder, Denise; Mussini, Cristina; Mitjà, Oriol; Soriano, Vicente ; Peschanski, Nicolas; Hayem, Gilles; Confalonieri, Marco; Piccirillo, Maria Carmela; Lobo-Ferreira, António; Bello Rivero, Iraldo; Turkia, Mika; Vinjevoll, Eivind H.; Griffin, Daniel O.; Hung, Ivan Fn (Expert opinion on investigational drugs, 2021)Background: COVID-19 has several overlapping phases. Treatments to date have focused on the late stage of disease in hospital. Yet, the pandemic is by propagated by the viral phase in out-patients. The current public health ... -
Antiretroviral Therapy for HIV-2 Infection in Non-Endemic Regions
Mendoza, Carmen de; Lozano, A. B.; Caballero, Estrella; Cabezas, Teresa; Ramos, José M.; Soriano, Vicente ; Spanish HIV-2 Network (AIDS Reviews, 01/2020)Human immunodeficiency virus type 2 (HIV-2) was isolated in AIDS patients in 1986. Around 1-2 million people are infected worldwide. The virus is less transmissible than HIV-1, being sexual contacts the most frequent route ...